Read + Share
Amedeo Smart
Independent Medical Education
Tinajero J, Koller P, Ali H. Ponatinib, asciminib and inotuzumab ozogamicin: A novel drug combination in acute lymphoblastic leukemia. Leuk Res 2023;129:107299.PMID: 37120933
Email
LinkedIn
Facebook
Twitter
Privacy Policy